Letter from the Editor and Introduction to the 2023 Thematic Issue
Immunol Invest. 2024 Feb 21:1-5. doi: 10.1080/08820139.2024.2321685. Online ahead of print.NO ABSTRACTPMID:38383287 | DOI:10.1080/08820139.2024.2321685 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Adam J Adler Source Type: research

Extracellular Vesicles and the Immune System: From Immunological Function to Therapeutic Application
Immunol Invest. 2024 Feb 21:1-4. doi: 10.1080/08820139.2024.2321684. Online ahead of print.NO ABSTRACTPMID:38383313 | DOI:10.1080/08820139.2024.2321684 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Aimin Jiang Source Type: research

Letter from the Editor and Introduction to the 2023 Thematic Issue
Immunol Invest. 2024 Feb 21:1-5. doi: 10.1080/08820139.2024.2321685. Online ahead of print.NO ABSTRACTPMID:38383287 | DOI:10.1080/08820139.2024.2321685 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Adam J Adler Source Type: research

Extracellular Vesicles and the Immune System: From Immunological Function to Therapeutic Application
Immunol Invest. 2024 Feb 21:1-4. doi: 10.1080/08820139.2024.2321684. Online ahead of print.NO ABSTRACTPMID:38383313 | DOI:10.1080/08820139.2024.2321684 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Aimin Jiang Source Type: research

Letter from the Editor and Introduction to the 2023 Thematic Issue
Immunol Invest. 2024 Feb 21:1-5. doi: 10.1080/08820139.2024.2321685. Online ahead of print.NO ABSTRACTPMID:38383287 | DOI:10.1080/08820139.2024.2321685 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Adam J Adler Source Type: research

Extracellular Vesicles and the Immune System: From Immunological Function to Therapeutic Application
Immunol Invest. 2024 Feb 21:1-4. doi: 10.1080/08820139.2024.2321684. Online ahead of print.NO ABSTRACTPMID:38383313 | DOI:10.1080/08820139.2024.2321684 (Source: Immunological Investigations)
Source: Immunological Investigations - February 21, 2024 Category: Allergy & Immunology Authors: Aimin Jiang Source Type: research

Role of Extracellular Vesicles in Immunity and Host Defense
Immunol Invest. 2024 Feb 13:1-16. doi: 10.1080/08820139.2024.2312896. Online ahead of print.ABSTRACTExtracellular vesicles (EVs) are membrane-bound structures released by cells and have become significant players in immune system functioning, primarily by facilitating cell-to-cell communication. Immune cells like neutrophils and dendritic cells release EVs containing bioactive molecules that modulate chemotaxis, activate immune cells, and induce inflammation. EVs also contribute to antigen presentation, lymphocyte activation, and immune tolerance. Moreover, EVs play pivotal roles in antimicrobial host defense. They deliver...
Source: Immunological Investigations - February 13, 2024 Category: Allergy & Immunology Authors: Puja Kumari Skylar S Wright Vijay A Rathinam Source Type: research

Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value
CONCLUSION: Serum BAFF level in NPSLE patients was correlated with lymphocytes and high serum BAFF protein level could assist in diagnosis and to predict adverse outcomes in NPSLE patients.PMID:38329469 | DOI:10.1080/08820139.2024.2309567 (Source: Immunological Investigations)
Source: Immunological Investigations - February 8, 2024 Category: Allergy & Immunology Authors: Jie Pang Yanxia Li Ran Tao Jing Li Feifei Wang Huaheng Xu Source Type: research

IL1RAP Exacerbates Sepsis-Induced Pulmonary and Spleen Injury Through Regulating CD4 < sup > + < /sup > T Lymphocyte Differentiation
CONCLUSIONS: We defined IL1RAP as a new target gene through NF-κB/MAPK pathways regulating CD4+ T lymphocyte differentiation mediated the progression of sepsis, which is potentially exploitable for immunotherapy.PMID:38329477 | DOI:10.1080/08820139.2024.2312898 (Source: Immunological Investigations)
Source: Immunological Investigations - February 8, 2024 Category: Allergy & Immunology Authors: Liou Huang Chunrong Wu Dan Xu Yuhui Cui Jianguo Tang Source Type: research

High Mobility Group Box 1 Gene Polymorphism and Serum High Mobility Group Box 1, Interleukin 1 Beta, and Alpha-Klotho Crosstalk in Severe COVID-19 Patients
CONCLUSION: The serum HMGB1, IL1β, and α-klotho may be severity markers and promising therapeutic targets for COVID-19 patients.PMID:38318856 | DOI:10.1080/08820139.2023.2299680 (Source: Immunological Investigations)
Source: Immunological Investigations - February 6, 2024 Category: Allergy & Immunology Authors: Maha Houssen Rasha El-Mahdy Nouran E Samra Yousra Tera Kamel Nayera Mostafa Manal M El-Desoky Fatma Azzahraa Hisham Asem A Hewidy Rehab A Elmorsey Hala Samaha Rasha Mahmoud Mona S Abdelhafez Source Type: research